Template:Herpes antiviral treatment: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
Neil.m.young (talk | contribs) (current recs from CDC) |
||
Line 1: | Line 1: | ||
====Initial Episode==== | ====Initial Episode<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>==== | ||
*[[Acyclovir]] OR | |||
**400mg PO q8hrs x 7-10 days | |||
**''or''200mg PO 5x/day x 7-10 days | |||
*[[Valacyclovir]] 1g PO q12hrs x 7-10 days OR | *[[Valacyclovir]] 1g PO q12hrs x 7-10 days OR | ||
*[[Famciclovir]] 250mg PO q8hrs x 7-10 days | |||
*[[Famciclovir]] 250mg PO q8hrs x 7 days | |||
====Recurrence==== | ====Recurrence==== |
Revision as of 06:49, 5 June 2015
Initial Episode[1]
- Acyclovir OR
- 400mg PO q8hrs x 7-10 days
- or200mg PO 5x/day x 7-10 days
- Valacyclovir 1g PO q12hrs x 7-10 days OR
- Famciclovir 250mg PO q8hrs x 7-10 days
Recurrence
- Valacyclovir OR
- 500mg PO q12hrs x 3 days
- or 1g PO qd x 5 days
- Acyclovir 800mg PO q12hrs x 5 days OR
- Famciclovir 1g PO q12hrs for 1 day
Suppressive Therapy
- Acyclovir 400mg PO q12hrs daily OR
- Famciclovir 250mg PO q12hrs daily OR
- Valacyclovir 1g PO daily
- ↑ Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.